Brazil · Delayed Price · Currency is BRL Biomm Statistics
Total Valuation
Biomm has a market cap or net worth of BRL 856.70 million. The enterprise value is 939.31 million.
| Market Cap | 856.70M |
| Enterprise Value | 939.31M |
Important Dates
The next confirmed earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Biomm has 136.85 million shares outstanding. The number of shares has increased by 7.30% in one year.
| Current Share Class | 136.85M |
| Shares Outstanding | 136.85M |
| Shares Change (YoY) | +7.30% |
| Shares Change (QoQ) | -0.36% |
| Owned by Insiders (%) | 12.66% |
| Owned by Institutions (%) | 93.98% |
| Float | 20.07M |
Valuation Ratios
The trailing PE ratio is 28.27.
| PE Ratio | 28.27 |
| Forward PE | n/a |
| PS Ratio | 2.23 |
| PB Ratio | 2.63 |
| P/TBV Ratio | 3.31 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 30.97 |
| EV / Sales | 2.44 |
| EV / EBITDA | 18.59 |
| EV / EBIT | 23.26 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.55, with a Debt / Equity ratio of 0.29.
| Current Ratio | 1.55 |
| Quick Ratio | 0.38 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | 1.84 |
| Debt / FCF | -0.91 |
| Interest Coverage | 3.90 |
Financial Efficiency
Return on equity (ROE) is 10.77% and return on invested capital (ROIC) is 8.55%.
| Return on Equity (ROE) | 10.77% |
| Return on Assets (ROA) | 4.89% |
| Return on Invested Capital (ROIC) | 8.55% |
| Return on Capital Employed (ROCE) | 10.70% |
| Weighted Average Cost of Capital (WACC) | 7.04% |
| Revenue Per Employee | 2.96M |
| Profits Per Employee | 233,269 |
| Employee Count | 130 |
| Asset Turnover | 0.74 |
| Inventory Turnover | 1.47 |
Taxes
In the past 12 months, Biomm has paid 5.51 million in taxes.
| Income Tax | 5.51M |
| Effective Tax Rate | 15.38% |
Stock Price Statistics
The stock price has decreased by -25.39% in the last 52 weeks. The beta is 0.46, so Biomm's price volatility has been lower than the market average.
| Beta (5Y) | 0.46 |
| 52-Week Price Change | -25.39% |
| 50-Day Moving Average | 6.21 |
| 200-Day Moving Average | 6.84 |
| Relative Strength Index (RSI) | 46.70 |
| Average Volume (20 Days) | 36,330 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Biomm had revenue of BRL 384.42 million and earned 30.33 million in profits. Earnings per share was 0.22.
| Revenue | 384.42M |
| Gross Profit | 138.63M |
| Operating Income | 40.38M |
| Pretax Income | 35.84M |
| Net Income | 30.33M |
| EBITDA | 50.10M |
| EBIT | 40.38M |
| Earnings Per Share (EPS) | 0.22 |
Balance Sheet
The company has 10.42 million in cash and 93.03 million in debt, with a net cash position of -82.61 million or -0.60 per share.
| Cash & Cash Equivalents | 10.42M |
| Total Debt | 93.03M |
| Net Cash | -82.61M |
| Net Cash Per Share | -0.60 |
| Equity (Book Value) | 325.20M |
| Book Value Per Share | 2.38 |
| Working Capital | 129.89M |
Cash Flow
In the last 12 months, operating cash flow was -76.29 million and capital expenditures -25.61 million, giving a free cash flow of -101.89 million.
| Operating Cash Flow | -76.29M |
| Capital Expenditures | -25.61M |
| Depreciation & Amortization | 9.72M |
| Net Borrowing | -15.07M |
| Free Cash Flow | -101.89M |
| FCF Per Share | -0.74 |
Margins
Gross margin is 36.06%, with operating and profit margins of 10.51% and 7.89%.
| Gross Margin | 36.06% |
| Operating Margin | 10.51% |
| Pretax Margin | 9.32% |
| Profit Margin | 7.89% |
| EBITDA Margin | 13.03% |
| EBIT Margin | 10.50% |
| FCF Margin | n/a |
Dividends & Yields
Biomm does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.30% |
| Shareholder Yield | -7.30% |
| Earnings Yield | 3.54% |
| FCF Yield | -11.89% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Biomm has an Altman Z-Score of 1.72 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.72 |
| Piotroski F-Score | 5 |